Qingke Biotechnology

Qingke Biotechnology is a leading provider of genetic technology services, consistently focusing on providing high-quality, convenient services and products for life science research. As a standout in the fields of gene sequencing and synthesis, Qingke Biotechnology always prioritizes industry needs, and guided by this, has successively established five major platforms: genetic testing, molecular biology reagents, chemical reagents, intelligent manufacturing, and synthetic biology. By introducing and learning from international advanced technologies, service concepts, and high-end talent from both domestic and international sources, as well as through independent innovation, the company has built a core technology system to serve scientific research in China. Since its establishment, Qingke Biotechnology has set up 16 localized experimental bases across the country, covering over 70% of the nation's regions through large base laboratories, provincial laboratories, and city offices. Currently, the company operates 41 3730xl sequencers and 54 192-channel synthesizers nationwide, providing tens of millions of gene sequencing and DNA synthesis services to 5,000 universities, research institutes, and enterprises. To practice the national innovation-driven development strategy and achieve "Made in China 2025," Qingke Biotechnology continuously increases R&D investment, introduces innovative talent, and strives to promote and enhance the construction of its five platforms, aiming to master core technologies, achieve upgrades from technology to industry, and form an industrial ecosystem. Qingke Biotechnology has gathered a large number of dynamic, motivated, and multi-disciplinary young talents, giving the company significant advantages across its five platforms: genetic testing, molecular biology reagents, chemical reagents, intelligent manufacturing, and synthetic biology. In the future, the people of Qingke will hold the dream of being the "engine of genetic technology," focus on building a talent development system, promote industrial upgrading, and strive to become a competitive national biotechnology enterprise.